Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression
- Stefanie Derer
- , Sven Berger
- , Martin Schlaeth
- , Tanja Schneider-Merck
- , Katja Klausz
- , Stefan Lohse
- , Marije B. Overdijk
- , Michael Dechant
- , Christian Kellner
- , Iris Nagelmeier
- , Andreas H. Scheel
- , Jeroen J.Lammerts van Bueren
- , Jan G.J. van de Winkel
- , Paul W.H.I. Parren
- , Matthias Peipp
- , Thomas Valerius*
*Corresponding author for this work
- University of Kiel
18
Link opens in a new tab
Citations
(Scopus)